PTCT
Ptc Therapeutics, Inc.Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-07-14 | Gravier Pierre |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 6,500 RSUs from a July 13, 2023 grant of 26,000 RSUs Includes 162 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2026. |
Common Stock
|
3,494 |
| 2026-07-09 | Almstead Neil Gregory |
CHIEF TECHNICAL OPS OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $90.00 to $90.70 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
2,464 |
| 2026-07-09 | Smith Mary L. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. |
Common Stock
|
10,000 |
| 2026-07-09 | Smith Mary L. |
Director |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. Currently exercisable. |
Stock Option (Right to Buy)
|
5,834 |
| 2026-07-09 | Almstead Neil Gregory |
CHIEF TECHNICAL OPS OFFICER |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. This option was granted on January 3, 2025, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2026, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2026. |
Stock Option (Right to Buy)
|
2,464 |
| 2026-07-09 | Almstead Neil Gregory |
CHIEF TECHNICAL OPS OFFICER |
Convert↑
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. |
Common Stock
|
2,464 |
| 2026-07-09 | Smith Mary L. |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. |
Common Stock
|
10,000 |
| 2026-07-09 | Smith Mary L. |
Director |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. Currently exercisable. |
Stock Option (Right to Buy)
|
10,000 |
| 2026-07-09 | Smith Mary L. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. |
Common Stock
|
5,834 |
| 2026-07-09 | Smith Mary L. |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. |
Common Stock
|
5,834 |
| 2026-07-07 | Almstead Neil Gregory |
CHIEF TECHNICAL OPS OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $88.29 to $89.28 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
11,369 |
| 2026-07-07 | Almstead Neil Gregory |
CHIEF TECHNICAL OPS OFFICER |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. This option was granted on January 5, 2023, and vests over four years, with 25% of the shares underlying the option vesting on January 5, 2024, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 5, 2024. |
Stock Option (Right to Buy)
|
24,613 |
| 2026-07-07 | Almstead Neil Gregory |
CHIEF TECHNICAL OPS OFFICER |
Convert↑
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. |
Common Stock
|
24,613 |
| 2026-07-07 | Almstead Neil Gregory |
CHIEF TECHNICAL OPS OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $87.00 to $87.81 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
3,956 |
| 2026-07-07 | Almstead Neil Gregory |
CHIEF TECHNICAL OPS OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $89.29 to $89.75 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
9,288 |
| 2026-07-06 | Almstead Neil Gregory |
CHIEF TECHNICAL OPS OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $86.03 to $86.74 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
10,090 |
| 2026-07-06 | Boulding Mark Elliott |
EXEC. VP AND CLO |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $82.76 to $83.68 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
387 |
| 2026-07-06 | Boulding Mark Elliott |
EXEC. VP AND CLO |
Convert↑
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025. |
Common Stock
|
2,266 |
| 2026-07-06 | Boulding Mark Elliott |
EXEC. VP AND CLO |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $85.18 to $86.17 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
645 |
| 2026-07-06 | Boulding Mark Elliott |
EXEC. VP AND CLO |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025. This option was granted on January 5, 2023 and vests over four years, with 25% of the shares underlying the option vesting on January 5, 2024, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 5, 2024. |
Stock Option (Right to Buy)
|
2,226 |
| 2026-07-06 | Boulding Mark Elliott |
EXEC. VP AND CLO |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $85.18 to $86.17 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
519 |
| 2026-07-06 | Almstead Neil Gregory |
CHIEF TECHNICAL OPS OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $85.00 to $85.98 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
8,786 |
| 2026-07-06 | Boulding Mark Elliott |
EXEC. VP AND CLO |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $83.98 to $84.94 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
1,036 |
| 2026-07-06 | Boulding Mark Elliott |
EXEC. VP AND CLO |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025. This option was granted on January 3, 2025, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2026, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2026. |
Stock Option (Right to Buy)
|
2,813 |
| 2026-07-06 | Almstead Neil Gregory |
CHIEF TECHNICAL OPS OFFICER |
Convert↑
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. |
Common Stock
|
18,876 |
| 2026-07-06 | Boulding Mark Elliott |
EXEC. VP AND CLO |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $83.98 to $84.94 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
833 |
| 2026-07-06 | Boulding Mark Elliott |
EXEC. VP AND CLO |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $86.18 to $86.73 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
745 |
| 2026-07-06 | Almstead Neil Gregory |
CHIEF TECHNICAL OPS OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $85.00 to $85.95 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
426 |
| 2026-07-06 | Almstead Neil Gregory |
CHIEF TECHNICAL OPS OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $87.00 to $87.07 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
2,474 |
| 2026-07-06 | Boulding Mark Elliott |
EXEC. VP AND CLO |
Convert↑
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025. |
Common Stock
|
2,813 |
| 2026-07-06 | Almstead Neil Gregory |
CHIEF TECHNICAL OPS OFFICER |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. This option was granted on January 5, 2023, and vests over four years, with 25% of the shares underlying the option vesting on January 5, 2024, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 5, 2024. |
Stock Option (Right to Buy)
|
2,474 |
| 2026-07-06 | Almstead Neil Gregory |
CHIEF TECHNICAL OPS OFFICER |
Convert↑
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. Includes 162 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2026. |
Common Stock
|
811 |
| 2026-07-06 | Almstead Neil Gregory |
CHIEF TECHNICAL OPS OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $86.02 to $86.73 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
385 |
| 2026-07-06 | Almstead Neil Gregory |
CHIEF TECHNICAL OPS OFFICER |
Convert↑
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. |
Common Stock
|
2,474 |
| 2026-07-06 | Boulding Mark Elliott |
EXEC. VP AND CLO |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $86.18 to $86.73 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
601 |
| 2026-07-06 | Boulding Mark Elliott |
EXEC. VP AND CLO |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $82.76 to $83.68 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
313 |
| 2026-07-06 | Almstead Neil Gregory |
CHIEF TECHNICAL OPS OFFICER |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. Currently exercisable. |
Stock Option (Right to Buy)
|
811 |
| 2026-07-06 | Almstead Neil Gregory |
CHIEF TECHNICAL OPS OFFICER |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. Currently exercisable. |
Stock Option (Right to Buy)
|
18,876 |
| 2026-06-26 | Almstead Neil Gregory |
CHIEF TECHNICAL OPS OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $85.07 to $85.30 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
412 |
| 2026-06-26 | Almstead Neil Gregory |
CHIEF TECHNICAL OPS OFFICER |
Convert↑
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. |
Common Stock
|
7,718 |
| 2026-06-26 | Almstead Neil Gregory |
CHIEF TECHNICAL OPS OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $85.00 to $85.75 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
7,718 |
| 2026-06-26 | Almstead Neil Gregory |
CHIEF TECHNICAL OPS OFFICER |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. Currently exercisable. |
Stock Option (Right to Buy)
|
412 |
| 2026-06-26 | Almstead Neil Gregory |
CHIEF TECHNICAL OPS OFFICER |
Convert↑
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. |
Common Stock
|
412 |
| 2026-06-26 | Almstead Neil Gregory |
CHIEF TECHNICAL OPS OFFICER |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. Currently exercisable. |
Stock Option (Right to Buy)
|
7,718 |
| 2026-06-25 | Almstead Neil Gregory |
CHIEF TECHNICAL OPS OFFICER |
Convert↑
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. |
Common Stock
|
100 |
| 2026-06-25 | Almstead Neil Gregory |
CHIEF TECHNICAL OPS OFFICER |
Convert↑
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. |
Common Stock
|
19,859 |
| 2026-06-25 | Almstead Neil Gregory |
CHIEF TECHNICAL OPS OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $85.00 to $85.84 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
582 |
| 2026-06-25 | Almstead Neil Gregory |
CHIEF TECHNICAL OPS OFFICER |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. Currently exercisable. |
Stock Option (Right to Buy)
|
1,001 |
| 2026-06-25 | Almstead Neil Gregory |
CHIEF TECHNICAL OPS OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $86.02 to $86.97 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
11,337 |
| 2026-06-25 | Almstead Neil Gregory |
CHIEF TECHNICAL OPS OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $85.00 to $85.98 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
Common Stock
|
8,522 |